Bactericidal activity of moxifloxacin against multidrug-resistant Streptoccocus pneumoniae at clinically achievable serum and epithelial lining fluid concentrations compared with three other antimicrobials

International Journal of Antimicrobial Agents

Volumn 24, Issue 4, 2004, Pages 334-338

  Cafini, Fabio ^a   Alou, Luis ^a   Sevillano, David ^a   Valero, Eva ^a   Prieto, José ^a  

^a Facultad de Medicina   (Spain)

Author keywords

Bactericidal; Epithelial lining fluid; Logarithmic; Serum; Stationary

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; AZITHROMYCIN; LEVOFLOXACIN; MOXIFLOXACIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; COMPARATIVE STUDY; EPITHELIUM; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIA;

ANTI-BACTERIAL AGENTS; AZA COMPOUNDS; AZITHROMYCIN; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE; HUMANS; MICROBIAL SENSITIVITY TESTS; OFLOXACIN; QUINOLINES; STREPTOCOCCUS PNEUMONIAE;

EID: 5644228896     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2004.04.015     Document Type: Article

References (18)

1. Baquero F. Trends in antibiotic resistance of respiratory pathogens: an analysis and commentary on a collaborative surveillance study. J. Antimicrob Chemother. 38(July (Suppl A)):1996;117-132
2. Perez-Trallero E., Fernandez-Mazarrasa C., Garcia-Rey C., et al. Spanish Surveillance Group for Respiratory Pathogens Antimicrobial susceptibilities of 1684 Streptococcus pneumoniae and 2039 Streptococcus pyogenes isolates and their ecological relationships: results of a 1-year (1998-1999) multicenter surveillance study in Spain. Antimicrob Agents Chemother. 45:2001;3334-3340
3. Pallares R, Fenoll A, Liñares J, The Spanish Pneumococcal Infection Study Network (G03/103). The epidemiology of antibiotic resistance in Streptococcus pneumoniae and the clinical relevance of resistance to cephalosporins, macrolides and quinolones. Int J Antimicrob Agents 2003;22(Suppl 1):15-24.
4. Perez-Trallero E, Garcia-Rey C, Martin-Sanchez AM, et al. Spanish Surveillance Group for Respiratory Pathogens (SAUCE Program). Activities of six different quinolones against clinical respiratory isolates of Streptococcus pneumoniae with reduced susceptibility to ciprofloxacin in Spain. Antimicrob Agents Chemother 2002:46;2665-7.
5. Liu P, Müller M, Derendorf H. Rational dosing of antibiotics: the use of plasma concentrations versus tissue concentrations. Int J Antimicrob Agents 2002;19:285-90.
6. Mercier R.C., Stumpo C., Rybak M.J. Effect of growth phase and pH on the in vitro activity of a new glycopeptide, oritavancin (LY333328), against Staphylococcus aureus and Enterococcus faecium. J. Antimicrob. Chemother. 50:2002;19-24
7. NCCLS, 2000. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 5th ed. Approved standard. NCCLS document M7-A5. Wayne, PA: NCCLS.
8. NCCLS, 1999. Methods for determining bactericidal activity of antimicrobial agents. Approved guideline. NCCLS document M26-A. Wayne, PA: NCCLS.
9. Pankuch G.A., Jacobs M.R., Appelbaum P.C. Bactericidal activity of daptomycin against Streptococcus pneumoniae compared with eight other antimicrobials. J. Antimicrob Chemother. 51:2003;443-446
10. Pankuch G.A., Nagai K., Davies T.A., Jacobs M.R., Appelbaum P.C. Antipneumococcal activity of BMS 284756 compared to those of six other agents. Antimicrob Agents Chemother. 46:2002;251-254
11. Boswell F.J., Andrews J.M., Wise R., Dalhoff A. Bactericidal properties of moxifloxacin and post-antibiotic effect. J. Antimicrob Chemother. 43(Suppl B):1999;43-49
12. Knudsen J.D., Frimodt-Moller N., Espersen F. Pharmacodynamics of penicillin are unaffected by bacterial growth phases of Streptococcus pneumoniae in the mouse peritonitis model. J. Antimicrob Chemother. 41:1998;451-459
13. Davey P.G., Barza M., Stuart M. Dose response of experimental Pseudomonas endophthalmitis to ciprofloxacin, gentamicin, and imipenem: evidence for resistance to "late" treatment of infections. J. Infect. Dis. 155:1987;518-523
14. Gerber A.U., Greter U., Segessenmann C., Kozak S. The impact of the pre-treatment interval on antimicrobial efficacy in a biological model. J. Antimicrob Chemother. 31(Suppl D):1993;29-39
15. Stevens D.L., Yan S., Bryant A.E. Penicillin-binding protein expression at different growth stages determines penicillin efficacy in vitro and in vivo: an explanation for the inoculum effect. J. Infect Dis. 167:1992;1401-1405
16. Gradelski E., Kolek B., Bonner D., Fung-Tomc J. Bactericidal mechanism of gatifloxacin compared with other quinolones. J. Antimicrob Chemother. 49:2002;185
17. Dalhoff A., Matutat S., Ullmann U. Effect of quinolones against slowly growing bacteria. Chemotherapy. 41:1995;92-99
18. Morosini M.I., Loza E., del Campo R., Almaraz F., Baquero F., Canton R. Fluoroquinolone-resistant Streptococcus pneumoniae in Spain: activities of garenoxacin against clinical isolates including strains with altered topoisomerases. Antimicrob Agents Chemother. 47:2003;2692-2695